<DOC>
	<DOCNO>NCT01273935</DOCNO>
	<brief_summary>The aim study evaluate low-response prevalence early antiplatelet therapy test influence different aspirin dosages patient acute ischemic stroke ( AIS ) .</brief_summary>
	<brief_title>Dose-Dependent Effect Early Antiplatelet Therapy Acute Ischemic Stroke</brief_title>
	<detailed_description>Antiplatelet agent important therapeutic option treat patient acute ischemic stroke prevent recurrent ischemic event death . The aim study evaluate low-response prevalence early antiplatelet therapy influence different aspirin dosages patient acute ischemic stroke ( AIS ) .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>suspect acute cerebrovascular ischemic event patient admit stroke unit antiplatelet therapy initiate severe liver disorder , current gastrointestinal disorder , congestive heart failure , lifethreatening malignancy personal family history bleeding disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Aspirin , Acute Cerebrovascular Ischemia , Platelet Function</keyword>
</DOC>